Ken Griffin’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Ken Griffin's EWTX Position: Q3 2026 in Review
Ken Griffin increased its Edgewise Therapeutics (EWTX) stake by 447% in Q3 2026, buying an estimated $89.3M and bringing the position to 2,570,840 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #970.
Ken Griffin first reported a position in EWTX in Q1 2021 and has held it in 23 quarters since. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Ken Griffin held 2,570,840 shares of Edgewise Therapeutics worth $104M as of Q3 2026.
- Ken Griffin bought 2,101,133 Edgewise Therapeutics shares in Q3 2026, an estimated $89.3M.
- Edgewise Therapeutics made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #970 holding.
- Ken Griffin first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 23 quarters since.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.